Press Releases

Review corporate releases related to governance, investor news, and other important announcements.

Sep 06, 2023

CORMEDIX INC. TO PRESENT AT THE H.C. WAINWRIGHT ANNUAL GLOBAL INVESTMENT CONFERENCE

Read more
Aug 30, 2023

CORMEDIX INC. ANNOUNCES ISSUANCE OF U.S. PATENT COVERING LEAD PRODUCT DEFENCATH

Read more
Aug 08, 2023

CORMEDIX INC. REPORTS SECOND QUARTER AND SIX MONTH 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Read more
Jul 27, 2023

CORMEDIX INC. TO REPORT SECOND QUARTER 2023 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON AUGUST 8, 2023

Read more
Jun 28, 2023

CORMEDIX INC. ANNOUNCES PRICING OF $40 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

Read more

CORMEDIX INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

Read more
Jun 21, 2023

CORMEDIX INC. ANNOUNCES FDA ACCEPTANCE OF RESUBMISSION OF NEW DRUG APPLICATION FOR DEFENCATH

Read more
Jun 15, 2023

CORMEDIX INC. ANNOUNCES STRATEGIC INITIATIVE WITH BOSTON MEDICAL CENTER TO REDUCE HEALTH DISPARITIES IN PATIENTS AT RISK FOR BLOODSTREAM INFECTIONS

Read more
May 30, 2023

CORMEDIX INC. TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE

Read more
May 16, 2023

CORMEDIX INC. ANNOUNCES RESUBMISSION OF NEW DRUG APPLICATION FOR DEFENCATH

Read more
See more